Search

Contributor:

Sahar Bedrood, MD, PhD

Innovative Interventional Glaucoma Technologies

Innovative Interventional Glaucoma Technologies

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Evaluating Risk of Topical Drops Versus Early Procedural Intervention

Evaluating Risk of Topical Drops Versus Early Procedural Intervention

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Nonadherence or Noncompliance Challenges in Glaucoma Management

Nonadherence or Noncompliance Challenges in Glaucoma Management

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Re-Evaluating the Conventional Glaucoma Treatment Journey

Re-Evaluating the Conventional Glaucoma Treatment Journey

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Evolution of the Interventional Glaucoma Mindset

Evolution of the Interventional Glaucoma Mindset

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Complex Case Management Pearls

Complex Case Management Pearls

Marjan Farid, MD; and Sahar Bedrood, MD, PhD

IGC 2024 Roundtable Discussion

IGC 2024 Roundtable Discussion

Analisa Arosemena, MD; Sahar Bedrood, MD, PhD; Larissa Camejo, MD; Christine Funke, MD; and Rachel G. Simpson, MD

Positioning Canaloplasty in the Glaucoma Treatment Paradigm

Positioning Canaloplasty in the Glaucoma Treatment Paradigm

Sahar Bedrood, MD, PhD

IGC 2024 Roundtable Discussion

IGC 2024 Roundtable Discussion

Analisa Arosemena, MD; Rachel G. Simpson, MD; Larissa Camejo, MD; Shivani Kamat, MD; Mary Qiu, MD; Christine Funke, MD; and Sahar Bedrood, MD, PhD

Canaloplasty with the iTrack Advance

Canaloplasty with the iTrack Advance

Sahar Bedrood, MD, PhD

Innovations in MIGS: The Impact of Reimbursement Changes

Innovations in MIGS: The Impact of Reimbursement Changes

I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Advancing Interventional Glaucoma

Advancing Interventional Glaucoma

Sahar Bedrood, MD, PhD

Shatter the Status Quo: Introducing iDose® TR

Shatter the Status Quo: Introducing iDose® TR

Ike Ahmed, MD, FRCSC; I. Paul Singh, MD; Mark J. Gallardo, MD; Jason Bacharach, MD; and Sahar Bedrood, MD, PhD

$Use of Wavefront Analysis and Optimizing Refractive Outcomes in Phaco/MIGS$

Use of Wavefront Analysis and Optimizing Refractive Outcomes in Phaco/MIGS

Sahar Bedrood, MD, PhD

iStent Infinite® Live Surgery Broadcast

iStent Infinite® Live Surgery Broadcast

Iqbal Ike K. Ahmed, MD, FRCSC; I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

The iStent Infinite®

The iStent Infinite®

Sahar Bedrood, MD, PhD; and I. Paul Singh, MD

Interventional Glaucoma

Interventional Glaucoma

I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

iStent Infinite® Surgery

iStent Infinite® Surgery

Iqbal Ike K. Ahmed, MD, FRCSC; I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Part Two: Important Considerations From GPS Trial Data

Part Two: Important Considerations From GPS Trial Data

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Sahar Bedrood, MD, PhD

Outcomes and Highlights of the GPS Trial

Outcomes and Highlights of the GPS Trial

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Sahar Bedrood, MD, PhD

Defining a Treatment Algorithm

Defining a Treatment Algorithm

Inder Paul Singh, MD; and Sahar Bedrood, MD, PhD

Innovations in Glaucoma: Microinvasive Bleb Procedures vs Trabeculectomy

Innovations in Glaucoma: Microinvasive Bleb Procedures vs Trabeculectomy

I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Alternative Delivery Systems for Glaucoma Meds: Reality or Pipe Dream

Alternative Delivery Systems for Glaucoma Meds: Reality or Pipe Dream

Sahar Bedrood, MD, PhD

MIGS Developments Anticipated in 2021

MIGS Developments Anticipated in 2021

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; Sahar Bedrood, MD, PhD; Monisha M. Vora, MD; Michael D. Greenwood, MD; Lorraine M. Provencher, MD; and Larissa Camejo, MD

My Pearls to Successfully Implant XEN Transconjunctivally

My Pearls to Successfully Implant XEN Transconjunctivally

Sahar Bedrood, MD, PhD

iStent <i>inject</i> in My Practice

iStent inject in My Practice

Sahar Bedrood, MD, PhD

iStent <i>inject</i>: The Glaucoma Surgeon's Perspective

iStent inject: The Glaucoma Surgeon's Perspective

Sahar Bedrood, MD, PhD

Tips for Success With a Second-Generation MIGS Device

Tips for Success With a Second-Generation MIGS Device

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Sahar Bedrood, MD, PhD

Measuring Change in Anterior Lamina Cribrosa Depth

Measuring Change in Anterior Lamina Cribrosa Depth

Neda Shamie, MD, Sahar Bedrood, MD, PhD